ADVANCE-2 and ADVANCE-3 Key Clinical Subgroups: BMI Sub-analysis Patient Characteristics
Characteristics Apixaban (n = 4236) Enoxaparin (n = 4228)
Age, years, mean ± SD 62.6 ± 11.4 62.5 ± 11.4
BMI, kg/m2, mean ± SD 28.6 ± 5.1 28.6 ± 4.9
<25 kg/m2, n 1017 989
25-29 kg/m2, n 1707 1651
≥30 kg/m2, n 1494 1571